We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.


The Explainer: How close is a Covid-19 vaccine?

We speak to one of the Oxford researchers working on a vaccine that has seen good results so far.

THE HUNT FOR a vaccine against Covid-19 is one of the most pressing items on the global agenda today.

Without a vaccine, we could be facing into years of curbed human activity and interaction, and clusters of coronavirus in countries across the world.

This week came the good news that a trial of a potential vaccine at Oxford University had seen some encouraging results. The vaccine being tested was found to be safe and induce an immune reaction in the early stages of the UK trial. 

Researchers at Oxford University conducted a Phase 1/2 trial involving 1,077 healthy adults and found the vaccine induced strong antibody and T cell immune responses for up to 56 days. That said, the trial is at too early a stage to be sure if it could meet the requirements needed for an effective vaccine against Covid-19. 

To find out more about the trial and the potential for this vaccine, we spoke to one of the researchers involved, Dr Teresa Lambe of the Jenner Institute at University of Oxford. 

The Explainer / SoundCloud

This episode was put together by presenter Sinéad O’Carroll, producer Aoife Barry, editor Laura Byrne and executive producer Christine Bohan. Guest was Dr Teresa Lambe of the Jenner Institute. Design by Palash Somani. Features a clip from The Lancet Voice.

Readers like you are keeping these stories free for everyone...
Our Explainer articles bring context and explanations in plain language to help make sense of complex issues. We're asking readers like you to support us so we can continue to provide helpful context to everyone, regardless of their ability to pay.

Your Voice
Readers Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel